Literature DB >> 33280245

Association of CHI3L1 gene variants with YKL-40 levels and hypertension incidence: A population-based nested case-control study in China.

Tian Xu1, Xiaowei Zheng2, Aili Wang2, Zhirong Guo2, Yonghong Zhang2.   

Abstract

YKL-40 was reported to be associated with the risk of hypertension. Whether the variants of CHI3L1 gene were associated with both YKL-40 levels and hypertension needs to be further elucidated. In a 1:1 matched case-control study of 507 pairs with available YKL-40 levels and DNA samples nested in a prospective cohort of Chinese subjects, the 15 tag single nucleotide polymorphisms (SNPs) of CHI3L1 gene were genotyped. The levels of YKL-40 among different genotypes of each SNP were compared after false discovery rate adjustment. Multivariable conditional logistic regression analyses were used to explore the association between the genotypes and the risk of hypertension. Subjects with the genetic variants for rs10399931, rs1538372, rs2071580, rs2297839 and rs4950928 had lower YKL-40 levels. The genetic variant for rs10399805 was associated with higher YKL-40 level. Subjects with the genotype of GA/AA of rs10399805 had a 1.34-fold risk of hypertension compared with those with GG genotype in the total population (P = .05). Subjects with heterozygote/rare homozygote genotype of rs4950928 and rs2297839 both had a significantly lower risk of hypertension compared with those with major homozygote genotype among men. The ORs (95% CIs) were 0.46 (0.23-0.89) and 0.49 (0.26-0.91), respectively. The above three SNPs could significantly improve the accuracy of risk prediction for hypertension based on the conventional factors. The genotypes of rs10399805, rs4950928 and rs2297839 may hopefully become stable biomarkers for predicting the risk of hypertension.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  CHI3L1 gene; YKL-40; hypertension; nested case-control study

Mesh:

Substances:

Year:  2020        PMID: 33280245      PMCID: PMC7812251          DOI: 10.1111/jcmm.16148

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  21 in total

Review 1.  Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer.

Authors:  Julia S Johansen
Journal:  Dan Med Bull       Date:  2006-05

2.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

3.  Systolic and diastolic hypertension independently predict CVD risk.

Authors:  Irene Fernández-Ruiz
Journal:  Nat Rev Cardiol       Date:  2019-10       Impact factor: 32.419

4.  New inflammatory markers for prediction of non-dipper blood pressure pattern in patients with essential hypertension: Serum YKL-40/Chitinase 3-like protein 1 levels and echocardiographic epicardial adipose tissue thickness.

Authors:  Eftal Murat Bakirci; Husnu Degirmenci; Hikmet Hamur; Murat Gunay; Barıs Gulhan; Merve Aydin; Zafer Kucuksu; Gokhan Ceyhun; Ergun Topal
Journal:  Clin Exp Hypertens       Date:  2015-04-28       Impact factor: 1.749

5.  Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.

Authors:  Carole Ober; Zheng Tan; Ying Sun; Jennifer D Possick; Lin Pan; Raluca Nicolae; Sadie Radford; Rodney R Parry; Andrea Heinzmann; Klaus A Deichmann; Lucille A Lester; James E Gern; Robert F Lemanske; Dan L Nicolae; Jack A Elias; Geoffrey L Chupp
Journal:  N Engl J Med       Date:  2008-04-09       Impact factor: 91.245

6.  Annotation of functional variation in personal genomes using RegulomeDB.

Authors:  Alan P Boyle; Eurie L Hong; Manoj Hariharan; Yong Cheng; Marc A Schaub; Maya Kasowski; Konrad J Karczewski; Julie Park; Benjamin C Hitz; Shuai Weng; J Michael Cherry; Michael Snyder
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

7.  Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects.

Authors:  Kaspar R Nielsen; Rudi Steffensen; Martin Boegsted; John Baech; Soeren Lundbye-Christensen; Merete L Hetland; Sophine B Krintel; Hans E Johnsen; Mette Nyegaard; Julia S Johansen
Journal:  Arthritis Res Ther       Date:  2011-06-29       Impact factor: 5.156

Review 8.  Advances in the Genetics of Hypertension: The Effect of Rare Variants.

Authors:  Alessia Russo; Cornelia Di Gaetano; Giovanni Cugliari; Giuseppe Matullo
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

9.  SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies.

Authors:  Zongli Xu; Jack A Taylor
Journal:  Nucleic Acids Res       Date:  2009-05-05       Impact factor: 16.971

10.  CHI3L1 polymorphisms associate with asthma in a Taiwanese population.

Authors:  Yishan Tsai; Yingchin Ko; Mingshyan Huang; Mengchih Lin; Chaochien Wu; Chinchou Wang; Yunxuan Chen; Jianing Li; Yuting Tseng; Tsunai Wang
Journal:  BMC Med Genet       Date:  2014-07-23       Impact factor: 2.103

View more
  1 in total

1.  Association of CHI3L1 gene variants with YKL-40 levels and hypertension incidence: A population-based nested case-control study in China.

Authors:  Tian Xu; Xiaowei Zheng; Aili Wang; Zhirong Guo; Yonghong Zhang
Journal:  J Cell Mol Med       Date:  2020-12-06       Impact factor: 5.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.